PIGY expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.169000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.658800E-01
Normal-vs-Stage2
3.883000E-01
Normal-vs-Stage3
3.467200E-01
Normal-vs-Stage4
7.493800E-01
Stage1-vs-Stage2
3.121000E-01
Stage1-vs-Stage3
2.968000E-01
Stage1-vs-Stage4
5.926200E-01
Stage2-vs-Stage3
6.300400E-01
Stage2-vs-Stage4
4.184800E-01
Stage3-vs-Stage4
3.468800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.290000E-01
Normal-vs-AfricanAmerican
8.317200E-01
Normal-vs-Asian
3.253800E-01
Caucasian-vs-AfricanAmerican
6.760600E-01
Caucasian-vs-Asian
5.493400E-01
AfricanAmerican-vs-Asian
3.684800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.113200E-01
Normal-vs-Female
7.857000E-01
Male-vs-Female
8.523800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.359200E-01
Normal-vs-Age(41-60Yrs)
8.996800E-01
Normal-vs-Age(61-80Yrs)
5.449600E-01
Normal-vs-Age(81-100Yrs)
1.636630E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.087000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.784200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.958400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.878100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.565600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.099200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.573370E-01
Normal-vs-Daily Drinker
4.056600E-01
Normal-vs-Weekly Drinker
2.298200E-01
Normal-vs-Occasional Drinker
9.027600E-01
Normal-vs-Social Drinker
7.640200E-01
Non Drinker-vs-Daily Drinker
1.934770E-01
Non Drinker-vs-Weekly Drinker
6.376600E-01
Non Drinker-vs-Occasional Drinker
3.916500E-03
Non Drinker-vs-Social Drinker
2.284000E-01
Daily Drinker-vs-Weekly Drinker
5.118200E-01
Daily Drinker-vs-Occasional Drinker
8.620400E-02
Daily Drinker-vs-Social Drinker
6.752800E-01
Weekly Drinker-vs-Occasional Drinker
3.724200E-02
Weekly Drinker-vs-Social Drinker
4.081000E-01
Occasional Drinker-vs-Social Drinker
4.339200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.388820E-01
Normal-vs-Grade 2
2.231600E-02
Normal-vs-Grade 3
3.682200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.013000E-01
Grade 1-vs-Grade 3
1.474810E-01
Grade 1-vs-Grade 4
1.388820E-01
Grade 2-vs-Grade 3
1.936350E-01
Grade 2-vs-Grade 4
2.231600E-02
Grade 3-vs-Grade 4
3.682200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.642400E-01
Normal-vs-NonDiabetic
6.615200E-01
Diabetic-vs-NonDiabetic
1.280420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.650600E-01
Normal-vs-NoPancreatitis
6.068200E-01
Pancreatitis-vs-NoPancreatitis
8.104200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.356000E-01
Normal-vs-N1
4.367200E-01
N0-vs-N1
1.277610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.379200E-01
Normal-vs-TP53-NonMutant
9.176600E-01
TP53-Mutant-vs-TP53-NonMutant
3.665000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
